A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Phase 3 Completed 381 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the safety and effectiveness of risperidone (an antipsychotic medication) in adolescents with schizophrenia over 6 months of treatment.

Timeline

Start: 2001-04
Primary completion: —
Completion: 2006-12

Publications

Pandina G, Kushner S, Karcher K, Haas M. An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia. Child Adolesc Psychiatry Ment Health. 2012 Jun 7;6(1):23. doi: 10.1186/1753-2000-6-23.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Risperidone	Other / unclassified	2 mg	Oral
Subject	Risperidone	Other / unclassified	6 mg	Oral

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Summary

Timeline

Publications

Drugs

Indications